Amino-terminal fragments of laminin γ2 chain stimulate migration of metastatic breast cancer cells by interacting with CD44

被引:12
|
作者
Sato, Hiroki [1 ,2 ]
Higashi, Shouichi [1 ,2 ]
Miyazaki, Kaoru [1 ,2 ,3 ]
机构
[1] Yokohama City Univ, Dept Genome Sci, Grad Sch Nanobiosci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan
[2] Yokohama City Univ, Div Cell Biol, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan
[3] Kanagawa Canc Ctr, Res Inst, Asahi Ku, Yokohama, Kanagawa 2418515, Japan
关键词
Laminin gamma 2 chain; CD44; Cell migration; Tumor invasion; Cancer stem cells; STEM-CELLS; TGF-BETA; COLORECTAL-CANCER; GROWTH-FACTOR; SHORT ARM; BIOLOGICAL-ACTIVITY; CARCINOMA-CELLS; TUMOR INVASION; EXPRESSION; VARIANT;
D O I
10.1007/s10585-015-9705-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Laminin gamma 2 (Lm gamma 2) chain, a subunit of the basement membrane protein laminin-332, is regarded as a typical cancer invasion marker. The overexpression of Lm gamma 2 chain by invasive cancer cells correlates with poor prognosis of cancer patients, and its forced expression in human cancer cells promotes their invasive growth in a nude mouse model. However, its actual roles in cancer progression, as well as the mechanism of its proinvasive effect, remain unclear. CD44 is known to be an important cancer stem cell marker and support cancer progression and stem cell functions. Here we demonstrate that amino-terminal fragments of Lm gamma 2 interact with CD44 on the membrane of breast cancer cells. Lm gamma 2 highly bound to the metastatic cell line MDA-MB-231 but poorly to the benign cell line MCF-7. The membrane receptor for Lm gamma 2 on MDA-MB-231 cells was identified to be the standard form of CD44 (CD44s) by co-immunoprecipitation, affinity chromatography and direct protein interaction assay. Lm gamma 2 interacted with CD44s through EGF-like repeat 2/3 in the Lm gamma 2 amino-terminus. Amino-terminal fragments of Lm gamma 2 induced the phosphorylation of CD44 cytoplasmic domain and stimulated migration of the cancer cells in a CD44-dependent manner. This migration was blocked by inhibitors of TGF-beta receptor I (TGF-beta RI) kinase. These results suggest that two important tumor markers, Lm gamma 2 and CD44, cooperate for cancer progression and possibly for cancer stem cell functions. TGF-beta RI may be involved in the Lm gamma 2/CD44 interaction.
引用
收藏
页码:405 / 415
页数:11
相关论文
共 50 条
  • [21] CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation
    Subramaniam, Venkateswaran
    Vincent, Isabella R.
    Gardner, Helena
    Chan, Emily
    Dhamko, Helena
    Jothy, Serge
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2007, 83 (02) : 207 - 215
  • [22] Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types
    de Beca, Francisco Ferro
    Caetano, Pedro
    Gerhard, Rene
    Alvarenga, Cesar Augusto
    Gomes, Madalena
    Paredes, Joana
    Schmitt, Fernando
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (03) : 187 - 191
  • [23] Regulation of CD44 expression by tumor necrosis factor-α and its potential role in breast cancer cell migration
    Li, Jun
    Zha, Xiao-Ming
    Wang, Rong
    Li, Xiao-Dong
    Xu, Bei
    Xu, Yan-Jie
    Yin, Yong-Mei
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (02) : 144 - 150
  • [24] Aspartyl Aminopeptidase Suppresses Proliferation, Invasion, and Stemness of Breast Cancer Cells via Targeting CD44
    Geng, Nanxi
    Zhang, Wenyu
    Li, Yang
    Li, Feng
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2019, 302 (12): : 2178 - 2185
  • [25] NF-κB Affects Proliferation and Invasiveness of Breast Cancer Cells by Regulating CD44 Expression
    Smith, Shannon M.
    Lyu, Yi Lisa
    Cai, Li
    PLOS ONE, 2014, 9 (09):
  • [26] CD44 Suppression Improved the Chemosensitivity of HT-29 Colorectal Cancer Cells to 5-Fluorouracil and Inhibited Cell Migration
    Najafi, Souzan
    Rahimi, Zohreh
    Mansoori, Behzad
    Mohammadi, Ali
    Mohammadnejad, Fatemeh
    Amini, Mohammad
    Mokhtazadeh, Ahad
    Asadzadeh, Zahra
    Cho, William Chi-Shing
    Baradaran, Behzad
    ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (03) : 551 - 562
  • [27] CD44/Cellular Prion Protein Interact in Multidrug Resistant Breast Cancer Cells and Correlate With Responses to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Cheng, Yuanyuan
    Tao, Lili
    Xu, Jiawen
    Li, Qingquan
    Yu, Juan
    Jin, Yiting
    Chen, Qi
    Xu, Zude
    Zou, Qiang
    Liu, Xiuping
    MOLECULAR CARCINOGENESIS, 2014, 53 (09) : 686 - 697
  • [28] CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel
    Muntimadugu, Eameema
    Kumar, Rajendra
    Saladi, Shantikumar
    Rafeeqi, Towseef Amin
    Khan, Wahid
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 143 : 532 - 546
  • [29] Measurements of heterotypic associations between cluster of differentiation CD74 and CD44 in human breast cancer-derived cells
    Al Ssadh, Hussain
    Spencer, Patrick S.
    Alabdulmenaim, Waleed
    Alghamdi, Rana
    Madar, Inamul Hasan
    Miranda-Sayago, Jose M.
    Fernandez, Nelson
    ONCOTARGET, 2017, 8 (54) : 92143 - 92156
  • [30] STAT3 mediates resistance of CD44(+)CD24(-/low) breast cancer stem cells to tamoxifen in vitro
    Wang, Xiaoyan
    Wang, Guozhu
    Zhao, Yi
    Liu, Xiaoan
    Ding, Qiang
    Shi, Jingping
    Ding, Yin
    Wang, Shui
    JOURNAL OF BIOMEDICAL RESEARCH, 2012, 26 (05): : 325 - 335